>Return to Research projects

Promoting Evidence Based ADHD Treatment

Recent findings from the Multimodal Treatment Study of ADHD Children (MTA) reveal that ADHD children treated pharmacologically via a university–based pharmacological intervention have improved treatment outcomes compared to ADHD children treated pharmacologically in community settings. This finding is not surprising since several studies have documented that the majority of community–based physicians fail to utilize systematic, evidence–based procedures with regard to evaluation and treatment decisions.

In accord with the "Bridging Science and Service" report issued by the National Institutes of Mental Health, the proposed study will translate evidence–based assessment and treatment procedures utilized in the MTA to community–based practices. Community–based pediatricians will be targeted since pediatricians are the most frequent providers of pharmacological treatment to ADHD children.

The primary goal of the proposed research is to assess the feasibility, utility, and effectiveness of a university–based assistive infrastructure (AI) in promoting the implementation of evidence–based practice procedures among community pediatricians. The AI is comprised of three main components:

The study will occur in three phases:

The study design will allow for between–groups and within–group comparisons of pediatricians’ utilization of the infrastructure, pediatricians’ practice behaviors, child outcomes, consumer satisfaction, and costs.

 

>Return to Research projects